Financhill
Back

Ultragenyx Pharmaceutical Vs. iBio Industry Stock Comparison

Sell
28

RARE
Ultragenyx Pharmaceutical

Last Price:
46.00
Seasonality Move:
12.78%
Sell
36

IBIO
iBio

Last Price:
2.45
Seasonality Move:
-11.6%
Sell
28
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $46.02. The Score for RARE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.45. The Score for IBIO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $46.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 34.61 Sell
Chaikin Money Flow: -427472 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.13 - 53.99) Sell
Bollinger Bands (100): (46.11 - 56.71) Sell

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 49.63 Sell
Chaikin Money Flow: 139651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.34 - 2.84) Sell
Bollinger Bands (100): (1.85 - 2.55) Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.28 Sell
20-day SMA: 49.45 Sell
50-day SMA: 53.38 Sell
200-day SMA: 48.05 Sell
8-day EMA: 46.62 Sell
20-day EMA: 48.96 Sell
50-day EMA: 51.25 Sell
200-day EMA: 48.71 Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.29 Buy
20-day SMA: 2.52 Sell
50-day SMA: 2.41 Buy
200-day SMA: 2.02 Buy
8-day EMA: 2.33 Buy
20-day EMA: 2.44 Buy
50-day EMA: 2.4 Buy
200-day EMA: 3.89 Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $1.17 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):